ENDRA stories favorable information from the Taeus Liver Units examine in MASLD
ENDRA Life Sciences has reported outcomes from a medical examine demonstrating the excessive measurement consistency of the Taeus Liver system in metabolic dysfunction-associated steatotic liver illness (MASLD).
The examine targeted on the intra-user reproducibility and repeatability of the Taeus Liver system, elements essential for constant long-term MASLD monitoring.
Uncover B2B advertising and marketing that delivers
Mix enterprise intelligence and editorial excellence to achieve engaged professionals throughout 36 main media platforms.
Extra info
It concerned 14 members, with a number of operators performing completely different measurements on every of them.
Researchers collected 56 distinctive information factors to guage the repeatability and reproducibility (R&R) of the system. This strategy helps regulatory validation by quantifying measurement variability arising from the system itself, somewhat than true variations between sufferers.
Such validation is key to medical resolution making concerning each diagnostic and therapy thresholds.
The Taeus Liver system achieved an intraclass correlation coefficient (ICC) of 0.89 and a normal error of measurement (SEM) of three.3%.
ENDRA Life Sciences CEO Alexander Tokman mentioned: “Whereas MRI-PDFF stays the gold normal for liver fats quantification, its excessive value and restricted availability create vital obstacles for the greater than two billion individuals affected by MASLD.
“These new efficiency information displaying an SEM of three.3% and an ICC of 0.89 strongly assist our perception that Taeus can ship constant outcomes akin to an MRI, however when it comes to affected person care and at a a lot decrease value. This addresses a essential want for physicians and pharmaceutical firms who require a diagnostic instrument to watch therapy regularly and affordably.”
The outcomes spotlight a stark distinction to conventional ultrasound strategies, which frequently undergo from excessive variability and subjective measurements. The system may standardize the evaluation of liver fats for routine medical use and for trials within the pharmaceutical business.
In February 2024, ENDRA introduced the set up of its first Taeus supply system at King’s School Hospital NHS Basis Belief in London in the UK.
